Tech Company Financing Transactions

TransPharma Medical Funding Round

TransPharma Medical closed a $18 million Series C funding round on 7/24/2006. Backers included Biomedical Investments, Evergreen Partners and Pitango Venture Capital.

Transaction Overview

Announced On
7/24/2006
Transaction Type
Venture Equity
Amount
$18,000,000
Round
Series C
Proceeds Purpose
TransPharma will use the funds to progress its lead project, transdermal hPTH (1-34), into advanced clinical trials. Earlier this year, the Company announced promising human clinical results demonstrating efficient and effective transdermal delivery of hPTH (1-34) for the treatment of osteoporosis.

Company Information

Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
2 Yodfat St. Northern Ind. Zone
Lod, 71291
Israel
Email Address
Overview
TransPharma Medical Ltd. is a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology.
Profile
TransPharma Medical LinkedIn Company Profile
Social Media
TransPharma Medical Company Twitter Account
Company News
TransPharma Medical News
Facebook
TransPharma Medical on Facebook
YouTube
TransPharma Medical on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Daphna Heffetz
  Daphna Heffetz LinkedIn Profile  Daphna Heffetz Twitter Account  Daphna Heffetz News  Daphna Heffetz on Facebook
Chief Operating Officer
Yael Kenan
  Yael Kenan LinkedIn Profile  Yael Kenan Twitter Account  Yael Kenan News  Yael Kenan on Facebook
VP - Bus. Development
Judith Kornfeld
  Judith Kornfeld LinkedIn Profile  Judith Kornfeld Twitter Account  Judith Kornfeld News  Judith Kornfeld on Facebook
VP - Engineering
Giora Arbel
  Giora Arbel LinkedIn Profile  Giora Arbel Twitter Account  Giora Arbel News  Giora Arbel on Facebook
VP - Finance
Ronit Nahary
  Ronit Nahary LinkedIn Profile  Ronit Nahary Twitter Account  Ronit Nahary News  Ronit Nahary on Facebook
VP - R & D
Galit Levin
  Galit Levin LinkedIn Profile  Galit Levin Twitter Account  Galit Levin News  Galit Levin on Facebook
VP - R & D
Zev Sohn
  Zev Sohn LinkedIn Profile  Zev Sohn Twitter Account  Zev Sohn News  Zev Sohn on Facebook
VP - Regulatory Affairs
Hana Gadassi
  Hana Gadassi LinkedIn Profile  Hana Gadassi Twitter Account  Hana Gadassi News  Hana Gadassi on Facebook


 

 

Browse more venture capital transactions:

Prev: 7/24/2006: Kythera Biopharmaceuticals venture capital transaction
Next: 7/24/2006: SEQUANS Communications venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document all VC transactions involving tech companies. VC transactions reported here come from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary